Is Amorepacific profitable in 2026?

Yes. Amorepacific Corp posted FY2025 operating profit of KRW 335.8 billion, up 52.3% year over year, on revenue of KRW 4.25 trillion. Q1 2026 operating profit rose further to KRW 126.7 billion, up 7.6%, as of March 31, 2026.

Is Amorepacific losing to Medicube maker APR Corp?

Domestically, yes. APR Corp (Medicube) posted KRW 365.4 billion in 2025 operating profit at a 23.9% margin, overtaking Amorepacific's 7.9% margin and beating it and LG H&H on domestic operating profit, per a February 9, 2026 Chosun report.

Could AI replace Amorepacific's business?

Unlikely soon. Amorepacific uses AI as an R&D and diagnostic tool, not a labor replacement: its MIT-co-developed Skinsight wearable, built on a 450,000-plus case skin dataset, won a CES Innovation Award in November 2025, while manufacturing and brand equity remain human-run.

Who owns Amorepacific Corporation?

The founding Suh family controls it through a holding structure. Amorepacific Holdings owns about 38% of Amorepacific Corp, while Chairman Suh Kyung-bae's direct stake fell to 8.74% after transferring 190,000 shares (~$22 million) to daughter Suh Ho-jung in March 2026.

Who is Amorepacific's biggest competitor?

Domestically, APR Corp (Medicube) overtook Amorepacific in 2025 operating profit (KRW 365.4 billion at a 23.9% margin versus Amorepacific's 7.9%). Historically LG H&H was the chief domestic rival; globally L'Oreal and Estee Lauder outscale it in marketing and distribution.

Is Amorepacific laying off workers in 2026?

No layoffs are reported. Its global workforce grew to roughly 4,901 employees by December 2025. In July 2026 it sold its Anseong health-functional-food plant as part of an asset-efficiency push, but this was a facility sale, not a reported headcount cut.

Consumer brands · subsidiary of Amorepacific Holdings (formerly Amorepacific Group; KRX: 002790) · South Korea

Amorepacific Corporation

amorepacific.com ↗

Korean beauty conglomerate behind Sulwhasoo and Laneige, KRW 4.25T revenue.

Defensible for now

Assessed 23 July 2026 · Evidence as of 23 July 2026

Real protection, with named pressure against it.

On the recordSince 23 July 2026 · Checkable from August 2026 · Every call on the record Checkpoint: H1 2026 earnings release, testing domestic margin trend against APR and US/EMEA growth pace

The call

Amorepacific is growing again abroad, but at home a faster, higher margin rival has already passed it on profit.

Amorepacific makes high-end skincare and cosmetics under labels like Sulwhasoo and Laneige, selling mainly across Asia. The company owns most of its own factories and has built a large database of skin science, which makes it harder for new rivals to copy overnight. However, newer Korean competitors like APR Corp and Medicube are already earning more profit on lower prices, and the company's own margins (around 8%) are much thinner than theirs (around 24%), which means Amorepacific is losing money per sale compared to them. The biggest wild card is whether the company's family leadership can make a smooth handover to the next generation without internal fights, plus whether its Sulwhasoo brand can keep growing in China.

Why

AI pressure: None apparent. AI trend tools and virtual try on shift discovery online, but no AI agent yet makes or sells skincare directly. Could AI do the core job? Unlikely.

Bigger players: APR Corp (Medicube). APR posted KRW 365.4B profit at 23.9% margin in 2025, beating Amorepacific's 7.9% margin and overtaking it domestically. Could a giant copy it? Probably.

What protects it. In house manufacturing for about 90% of products plus a 450,000 case skin dataset and entrenched retail and duty free distribution.

What would change this call

Amorepacific's H1 2026 earnings release (~August 2026) shows domestic margin trend. Would show whether APR/Medicube's domestic profit lead over Amorepacific is widening or narrowing.
Resolution or escalation of the Suh Ho-jung vs Suh Min-jung succession dispute, including further share transfers. Would show whether governance instability is deepening or being contained.
Greater China sales trend for Sulwhasoo in upcoming quarterly reports. Would show whether the China drag on Amorepacific is stabilizing or worsening.

Key numbers

FY2025 revenue KRW 4.25T, up 9.5% YoY (2025-12-31)
FY2025 operating profit KRW 335.8B, up 52.3% (2025-12-31)
APR Corp 2025 operating margin 23.9% vs Amorepacific 7.9% (2025-12-31)

Named risks

Unresolved Suh family succession dispute between two daughters could trigger governance conflict. Severity: high
APR/Medicube sustaining much higher domestic margins pressures Amorepacific's pricing power. Severity: high
Greater China sales remain weak with Sulwhasoo store closures cited in Q4 2025. Severity: medium
Ongoing asset divestitures (plants, offices) signal restructuring uncertainty. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
APR Corp (Medicube)	losing to	APR's 23.9% 2025 margin beat Amorepacific's 7.9%, overtaking it domestically, Feb 2026
LG Household & Health Care	gaining on	LG H&H 2025 sales fell 6.7% and profit fell 62.8% while Amorepacific profit rose 52.3%
L'Oreal and Estee Lauder	contesting	Global scale rivals as Amorepacific expands Americas (+20%) and EMEA (+42%) in FY2025
C-beauty brands (Proya, Florasis)	losing to	Cited eroding Amorepacific's China share via cheaper local formulations, 2026
Shiseido	contesting	Competes on heritage-plus-science premium skincare positioning in Asia

Questions people ask

Is Amorepacific profitable in 2026?: Yes. Amorepacific Corp posted FY2025 operating profit of KRW 335.8 billion, up 52.3% year over year, on revenue of KRW 4.25 trillion. Q1 2026 operating profit rose further to KRW 126.7 billion, up 7.6%, as of March 31, 2026.
Is Amorepacific losing to Medicube maker APR Corp?: Domestically, yes. APR Corp (Medicube) posted KRW 365.4 billion in 2025 operating profit at a 23.9% margin, overtaking Amorepacific's 7.9% margin and beating it and LG H&H on domestic operating profit, per a February 9, 2026 Chosun report.
Could AI replace Amorepacific's business?: Unlikely soon. Amorepacific uses AI as an R&D and diagnostic tool, not a labor replacement: its MIT-co-developed Skinsight wearable, built on a 450,000-plus case skin dataset, won a CES Innovation Award in November 2025, while manufacturing and brand equity remain human-run.
Who owns Amorepacific Corporation?: The founding Suh family controls it through a holding structure. Amorepacific Holdings owns about 38% of Amorepacific Corp, while Chairman Suh Kyung-bae's direct stake fell to 8.74% after transferring 190,000 shares (~$22 million) to daughter Suh Ho-jung in March 2026.
Who is Amorepacific's biggest competitor?: Domestically, APR Corp (Medicube) overtook Amorepacific in 2025 operating profit (KRW 365.4 billion at a 23.9% margin versus Amorepacific's 7.9%). Historically LG H&H was the chief domestic rival; globally L'Oreal and Estee Lauder outscale it in marketing and distribution.
Is Amorepacific laying off workers in 2026?: No layoffs are reported. Its global workforce grew to roughly 4,901 employees by December 2025. In July 2026 it sold its Anseong health-functional-food plant as part of an asset-efficiency push, but this was a facility sale, not a reported headcount cut.

Timeline

2026-07-19Amorepacific sells Anseong health-functional-food plant to sharpen R&D focus
2026-06-26Amorepacific Group reports highest-ever Amazon Prime Day revenue (June 23-26)
2026-03-31Q1 2026: revenue KRW 1.1358T (+6.4%), operating profit KRW 126.7B (+7.6%)
2026-03Suh Kyung-bae transfers 190,000 shares (~$22M) to daughter Suh Ho-jung, stake falls to 8.74%
2026-02-08FY2025 results: revenue KRW 4.25T (+9.5%), operating profit KRW 335.8B (+52.3%)
2026-01Skinsight AI skin platform integrated into Samsung's AI Beauty Mirror at CES 2026
2025-11-13Skinsight wins 7th consecutive CES Innovation Award
2025-04-30Amorepacific consolidates ~93.2% ownership of COSRX after call option and extension

Head to head

Amorepacific Corporation vs LG Household & Health Care Ltd.

Revision history

23 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Estée Lauder LVMH Moet Hennessy Louis Vuitton Chow Sang Sang Holdings International Limited